Artículos de revistas sobre el tema "T1AM"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "T1AM".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Rogowski, Michael, Lorenza Bellusci, Martina Sabatini, Simona Rapposelli, Shaikh M. Rahman, Grazia Chiellini y Fariba M. Assadi-Porter. "Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway". International Journal of Molecular Sciences 20, n.º 16 (20 de agosto de 2019): 4054. http://dx.doi.org/10.3390/ijms20164054.
Texto completoSaba, Alessandro, Grazia Chiellini, Sabina Frascarelli, Maja Marchini, Sandra Ghelardoni, Andrea Raffaelli, Massimo Tonacchera, Paolo Vitti, Thomas S. Scanlan y Riccardo Zucchi. "Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine". Endocrinology 151, n.º 10 (25 de agosto de 2010): 5063–73. http://dx.doi.org/10.1210/en.2010-0491.
Texto completoDinter, Juliane, Noushafarin Khajavi, Jessica Mühlhaus, Carolin Leonie Wienchol, Maxi Cöster, Thomas Hermsdorf, Claudia Stäubert et al. "The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling". European Thyroid Journal 4, Suppl. 1 (2015): 21–29. http://dx.doi.org/10.1159/000381801.
Texto completoGhelardoni, Sandra, Grazia Chiellini, Sabina Frascarelli, Alessandro Saba y Riccardo Zucchi. "Uptake and metabolic effects of 3-iodothyronamine in hepatocytes". Journal of Endocrinology 221, n.º 1 (abril de 2014): 101–10. http://dx.doi.org/10.1530/joe-13-0311.
Texto completoDinter, Juliane, Jessica Mühlhaus, Simon Friedrich Jacobi, Carolin Leonie Wienchol, Maxi Cöster, Jaroslawna Meister, Carolin Stephanie Hoefig et al. "3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling". Journal of Molecular Endocrinology 54, n.º 3 (junio de 2015): 205–16. http://dx.doi.org/10.1530/jme-15-0003.
Texto completoHaiyan, Zhou, Hu Bailong, Zhang Bei, Wang Yiming y Liu Xingde. "Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM)". BioMed Research International 2020 (20 de junio de 2020): 1–10. http://dx.doi.org/10.1155/2020/1302453.
Texto completoCöster, Maxi, Heike Biebermann, Torsten Schöneberg y Claudia Stäubert. "Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1". European Thyroid Journal 4, Suppl. 1 (2015): 9–20. http://dx.doi.org/10.1159/000430839.
Texto completoGencarelli, Manuela, Annunziatina Laurino, Elisa Landucci, Daniela Buonvicino, Costanza Mazzantini, Grazia Chiellini y Laura Raimondi. "3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes". Biology 9, n.º 5 (4 de mayo de 2020): 95. http://dx.doi.org/10.3390/biology9050095.
Texto completoGalli, Elena, Maja Marchini, Alessandro Saba, Sergio Berti, Massimo Tonacchera, Paolo Vitti, Thomas S. Scanlan, Giorgio Iervasi y Riccardo Zucchi. "Detection of 3-Iodothyronamine in Human Patients: A Preliminary Study". Journal of Clinical Endocrinology & Metabolism 97, n.º 1 (1 de enero de 2012): E69—E74. http://dx.doi.org/10.1210/jc.2011-1115.
Texto completoHackenmueller, Sarah A., Maja Marchini, Alessandro Saba, Riccardo Zucchi y Thomas S. Scanlan. "Biosynthesis of 3-Iodothyronamine (T1AM) Is Dependent on the Sodium-Iodide Symporter and Thyroperoxidase but Does Not Involve Extrathyroidal Metabolism of T4". Endocrinology 153, n.º 11 (1 de noviembre de 2012): 5659–67. http://dx.doi.org/10.1210/en.2012-1254.
Texto completoAgretti, Patrizia, Giuseppina De Marco, Laura Russo, Alessandro Saba, Andrea Raffaelli, Maja Marchini, Grazia Chiellini et al. "3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells". Journal of Molecular Endocrinology 47, n.º 1 (21 de abril de 2011): 23–32. http://dx.doi.org/10.1530/jme-10-0168.
Texto completoScanlan, Thomas S. "3-Iodothyronamine (T1AM): A New Player on the Thyroid Endocrine Team?" Endocrinology 150, n.º 3 (30 de diciembre de 2008): 1108–11. http://dx.doi.org/10.1210/en.2008-1596.
Texto completoGencarelli, Manuela, Maura Lodovici, Lorenza Bellusci, Laura Raimondi y Annunziatina Laurino. "Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1)". International Journal of Molecular Sciences 23, n.º 5 (28 de febrero de 2022): 2718. http://dx.doi.org/10.3390/ijms23052718.
Texto completoAckermans, M. T., L. P. Klieverik, P. Ringeling, E. Endert, A. Kalsbeek y E. Fliers. "An online solid-phase extraction–liquid chromatography–tandem mass spectrometry method to study the presence of thyronamines in plasma and tissue and their putative conversion from 13C6-thyroxine". Journal of Endocrinology 206, n.º 3 (5 de julio de 2010): 327–34. http://dx.doi.org/10.1677/joe-10-0060.
Texto completoRutigliano, Grazia, Lavinia Bandini, Simona Sestito y Grazia Chiellini. "3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?" International Journal of Molecular Sciences 21, n.º 6 (15 de marzo de 2020): 2005. http://dx.doi.org/10.3390/ijms21062005.
Texto completodi Leo, Nicoletta, Stefania Moscato, Marco Borso', Simona Sestito, Beatrice Polini, Lavinia Bandini, Agostina Grillone et al. "Delivery of Thyronamines (TAMs) to the Brain: A Preliminary Study". Molecules 26, n.º 6 (14 de marzo de 2021): 1616. http://dx.doi.org/10.3390/molecules26061616.
Texto completoBandini, Lavinia, Ginevra Sacripanti, Marco Borsò, Maria Tartaria, Maria Pia Fogliaro, Giulia Giannini, Vittoria Carnicelli et al. "Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1)". Life 12, n.º 9 (30 de agosto de 2022): 1352. http://dx.doi.org/10.3390/life12091352.
Texto completoBiebermann, Heike y Gunnar Kleinau. "3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors". Experimental and Clinical Endocrinology & Diabetes 128, n.º 06/07 (7 de noviembre de 2019): 395–400. http://dx.doi.org/10.1055/a-1022-1554.
Texto completoHoefig, Carolin S., Tilo Wuensch, Eddy Rijntjes, Ina Lehmphul, Hannelore Daniel, Ulrich Schweizer, Jens Mittag y Josef Köhrle. "Biosynthesis of 3-Iodothyronamine From T4 in Murine Intestinal Tissue". Endocrinology 156, n.º 11 (8 de septiembre de 2015): 4356–64. http://dx.doi.org/10.1210/en.2014-1499.
Texto completoChiellini, Grazia, Paola Erba, Vittoria Carnicelli, Chiara Manfredi, Sabina Frascarelli, Sandra Ghelardoni, Giuliano Mariani y Riccardo Zucchi. "Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors". Journal of Endocrinology 213, n.º 3 (22 de marzo de 2012): 223–30. http://dx.doi.org/10.1530/joe-12-0055.
Texto completoWei, Bo, Hanbing Zhao, Bailong Hu, Lujun Dai, Guoning Zhang, Lili Mo, Niwen Huang et al. "T1AM Attenuates the Hypoxia/Reoxygenation-Induced Necroptosis of H9C2 Cardiomyocytes via RIPK1/RIPK3 Pathway". BioMed Research International 2022 (28 de febrero de 2022): 1–8. http://dx.doi.org/10.1155/2022/4833791.
Texto completoDiab, Nour, Sameer Desale, Mark Danielsen, Josef Köhrle, Nawar Shara y Jacqueline Jonklaas. "Changes in Thyroid Metabolites after Liothyronine Administration: A Secondary Analysis of Two Clinical Trials That Incorporated Pharmacokinetic Data". Metabolites 12, n.º 6 (24 de mayo de 2022): 476. http://dx.doi.org/10.3390/metabo12060476.
Texto completoKlieverik, Lars P., Ewout Foppen, Mariëtte T. Ackermans, Mireille J. Serlie, Hans P. Sauerwein, Thomas S. Scanlan, David K. Grandy, Eric Fliers y Andries Kalsbeek. "Central effects of thyronamines on glucose metabolism in rats". Journal of Endocrinology 201, n.º 3 (6 de marzo de 2009): 377–86. http://dx.doi.org/10.1677/joe-09-0043.
Texto completoHomuth, Georg, Julika Lietzow, Nancy Schanze, Janine Golchert y Josef Köhrle. "Endocrine, Metabolic and Pharmacological Effects of Thyronamines (TAM), Thyroacetic Acids (TA) and Thyroid Hormone Metabolites (THM) – Evidence from in vitro, Cellular, Experimental Animal and Human Studies". Experimental and Clinical Endocrinology & Diabetes 128, n.º 06/07 (25 de mayo de 2020): 401–13. http://dx.doi.org/10.1055/a-1139-9200.
Texto completoBellusci, Lorenza, Massimiliano Runfola, Vittoria Carnicelli, Simona Sestito, Federica Fulceri, Filippo Santucci, Paola Lenzi et al. "Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6". Molecules 25, n.º 5 (26 de febrero de 2020): 1054. http://dx.doi.org/10.3390/molecules25051054.
Texto completoScanlan, Thomas S. "Endogenous 3-Iodothyronamine (T1AM): More Than We Bargained For". Journal of Clinical Endocrinology & Metabolism 96, n.º 6 (junio de 2011): 1674–76. http://dx.doi.org/10.1210/jc.2011-0688.
Texto completoLaurino, Annunziatina, Rosanna Matucci, Giulio Vistoli y Laura Raimondi. "3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors". European Journal of Pharmacology 793 (diciembre de 2016): 35–42. http://dx.doi.org/10.1016/j.ejphar.2016.10.027.
Texto completoStavrou, Stavroula, Michael Gratz, Eileen Tremmel, Christina Kuhn, Simone Hofmann, Helene Heidegger, Mina Peryanova et al. "TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC". Endocrine Connections 7, n.º 2 (febrero de 2018): 372–84. http://dx.doi.org/10.1530/ec-17-0272.
Texto completoMiyakawa, Motonori y Thomas S. Scanlan. "Synthesis of [125I]‐, [2H]‐, and [3H]‐Labeled 3‐Iodothyronamine (T1AM)". Synthetic Communications 36, n.º 7 (1 de marzo de 2006): 891–902. http://dx.doi.org/10.1080/00397910500466074.
Texto completoIanculescu, Alexandra G. y Thomas S. Scanlan. "3-Iodothyronamine (T1AM): a new chapter of thyroid hormone endocrinology?" Molecular BioSystems 6, n.º 8 (2010): 1338. http://dx.doi.org/10.1039/b926583j.
Texto completoGratz, Michael J., Stavroula Stavrou, Christina Kuhn, Simone Hofmann, Kerstin Hermelink, Helene Heidegger, Stefan Hutter et al. "Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages". Endocrine Connections 7, n.º 5 (mayo de 2018): 727–38. http://dx.doi.org/10.1530/ec-18-0126.
Texto completoTozzi, Francesca, Grazia Rutigliano, Marco Borsò, Chiara Falcicchia, Riccardo Zucchi y Nicola Origlia. "T1AM-TAAR1 signalling protects against OGD-induced synaptic dysfunction in the entorhinal cortex". Neurobiology of Disease 151 (abril de 2021): 105271. http://dx.doi.org/10.1016/j.nbd.2021.105271.
Texto completola Cour, Jeppe Lerche, Heidi M. Christensen, Josef Köhrle, Ina Lehmphul, Caroline Kistorp, Birte Nygaard y Jens Faber. "Association Between 3-Iodothyronamine (T1am) Concentrations and Left Ventricular Function in Chronic Heart Failure". Journal of Clinical Endocrinology & Metabolism 104, n.º 4 (31 de octubre de 2018): 1232–38. http://dx.doi.org/10.1210/jc.2018-01466.
Texto completoChiellini, Grazia, Sandra Ghelardoni, Sabina Frascarelli, Simonetta Testoni, Thomas S. Scanlan, David K. Grandy y Riccardo Zucchi. "3-Iodothyronamine (T1AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart". Journal of Molecular and Cellular Cardiology 44, n.º 4 (abril de 2008): 773–74. http://dx.doi.org/10.1016/j.yjmcc.2008.02.149.
Texto completoGonçalves, Luís M., Manuela M. Moreira, Carla F. Azevedo, Inês M. Valente, João C. Sousa, Thomas S. Scanlan, Richard G. Compton y José A. Rodrigues. "Proof of Concept of the Electrochemical Sensing of 3-Iodothyronamine (T1AM) and Thyronamine (T0AM)". ChemElectroChem 1, n.º 10 (25 de agosto de 2014): 1623–26. http://dx.doi.org/10.1002/celc.201402165.
Texto completoLi, Zhong-Min, Manuel Miller, Sogol Gachkar, Jens Mittag, Sonja C. Schriever, Paul T. Pfluger, Karl-Werner Schramm y Meri De Angelis. "Determination of 3-iodothyronamine (3-T1AM) in mouse liver using liquid chromatography-tandem mass spectrometry". Journal of Chromatography B 1165 (febrero de 2021): 122553. http://dx.doi.org/10.1016/j.jchromb.2021.122553.
Texto completoLangouche, Lies, Ina Lehmphul, Sarah Vander Perre, Josef Köhrle y Greet Van den Berghe. "Circulating 3-T1AM and 3,5-T2 in Critically Ill Patients: A Cross-Sectional Observational Study". Thyroid 26, n.º 12 (diciembre de 2016): 1674–80. http://dx.doi.org/10.1089/thy.2016.0214.
Texto completoLaurino, Annunziatina, Ersilia Lucenteforte, Gaetano De Siena y Laura Raimondi. "The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice". Hormones and Behavior 94 (agosto de 2017): 93–96. http://dx.doi.org/10.1016/j.yhbeh.2017.07.003.
Texto completoLaurino, Annunziatina, Manuela Gencarelli y Laura Raimondi. "The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection". European Journal of Pharmacology 912 (diciembre de 2021): 174606. http://dx.doi.org/10.1016/j.ejphar.2021.174606.
Texto completoManni, Maria Elena, Gaetano De Siena, Alessandro Saba, Maja Marchini, Elisa Landucci, Elisabetta Gerace, Marina Zazzeri et al. "Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold". British Journal of Pharmacology 168, n.º 2 (20 de diciembre de 2012): 354–62. http://dx.doi.org/10.1111/j.1476-5381.2012.02137.x.
Texto completoAssadi-Porter, Fariba, Hannah Reiland, Martina Sabatini, Leonardo Lorenzini, Vittoria Carnicelli, Micheal Rogowski, Ebru Selen Alpergin et al. "Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression". International Journal of Molecular Sciences 19, n.º 5 (22 de mayo de 2018): 1535. http://dx.doi.org/10.3390/ijms19051535.
Texto completoLanducci, Elisa, Manuela Gencarelli, Costanza Mazzantini, Annunziatina Laurino, Domenico Edoardo Pellegrini-Giampietro y Laura Raimondi. "N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity". Neurochemistry International 129 (octubre de 2019): 104460. http://dx.doi.org/10.1016/j.neuint.2019.05.004.
Texto completoHan, Hong-Seok, Hyun-June Paik, Jai Min Ryu, Sungmin Park, Ha Woo Yi, Suyeon Bae, Sekyung Lee et al. "Comparison of prognosis and specific features according to tumor size in small-sized breast cancer with extensive lymph node involvement." Journal of Clinical Oncology 33, n.º 28_suppl (1 de octubre de 2015): 81. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.81.
Texto completoLaurino, Annunziatina, Gaetano De Siena, Alessandro Saba, Grazia Chiellini, Elisa Landucci, Riccardo Zucchi y Laura Raimondi. "In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine". European Journal of Pharmacology 761 (agosto de 2015): 130–34. http://dx.doi.org/10.1016/j.ejphar.2015.04.038.
Texto completoVogelsang, Tilman L. R., Aurelia Vattai, Elisa Schmoeckel, Till Kaltofen, Anca Chelariu-Raicu, Mingjun Zheng, Sven Mahner, Doris Mayr, Udo Jeschke y Fabian Trillsch. "Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer". International Journal of Molecular Sciences 22, n.º 16 (6 de agosto de 2021): 8479. http://dx.doi.org/10.3390/ijms22168479.
Texto completoDietrich, Johannes W., Patrick Müller, Fabian Schiedat, Markus Schlömicher, Justus Strauch, Apostolos Chatzitomaris, Harald H. Klein et al. "Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling". European Thyroid Journal 4, n.º 2 (2015): 129–37. http://dx.doi.org/10.1159/000381543.
Texto completoRathmann, Daniel, Eddy Rijntjes, Julika Lietzow y Josef Köhrle. "Quantitative Analysis of Thyroid Hormone Metabolites in Cell Culture Samples Using LC-MS/MS". European Thyroid Journal 4, Suppl. 1 (2015): 51–58. http://dx.doi.org/10.1159/000430840.
Texto completoFehrenbacher, Louis, Angela M. Capra, Charles P. Quesenberry, Regan Fulton, Parveen Shiraz y Laurel A. Habel. "Distant Invasive Breast Cancer Recurrence Risk in Human Epidermal Growth Factor Receptor 2–Positive T1a and T1b Node-Negative Localized Breast Cancer Diagnosed From 2000 to 2006: A Cohort From an Integrated Health Care Delivery System". Journal of Clinical Oncology 32, n.º 20 (10 de julio de 2014): 2151–58. http://dx.doi.org/10.1200/jco.2013.52.0858.
Texto completoKanayama, Naoki, Mitsuyoshi Ueda, Haruyuki Atomi y Atsuo Tanaka. "Genetic Evaluation of Physiological Functions of Thiolase Isozymes in the n-Alkane-Assimilating YeastCandida tropicalis". Journal of Bacteriology 180, n.º 3 (1 de febrero de 1998): 690–98. http://dx.doi.org/10.1128/jb.180.3.690-698.1998.
Texto completoOyama, Tsuneo y Akiko Takahashi. "PS02.025: CHARACTERISTICS OF SUPERFICIAL BASALOID SQUAMOUS CELL CARCINOMA TREATED BY ENDOSCOPIC RESECTION". Diseases of the Esophagus 31, Supplement_1 (1 de septiembre de 2018): 127. http://dx.doi.org/10.1093/dote/doy089.ps02.025.
Texto completo